IOL Chemicals And Pharmaceuticals (NSE:IOLCP) 3-Year EBITDA Growth Rate : -25.40% (As of Sep. 2024)

View and export this data going back to 2010. Start your Free Trial

What is IOL Chemicals And Pharmaceuticals 3-Year EBITDA Growth Rate?

IOL Chemicals And Pharmaceuticals's EBITDA per Share for the three months ended in Sep. 2024 was ₹8.17.

During the past 12 months, IOL Chemicals And Pharmaceuticals's average EBITDA Per Share Growth Rate was -29.30% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -25.40% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -16.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of IOL Chemicals And Pharmaceuticals was 119.90% per year. The lowest was -41.20% per year. And the median was -6.90% per year.

Competitive Comparison of IOL Chemicals And Pharmaceuticals's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, IOL Chemicals And Pharmaceuticals's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

IOL Chemicals And Pharmaceuticals's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, IOL Chemicals And Pharmaceuticals's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where IOL Chemicals And Pharmaceuticals's 3-Year EBITDA Growth Rate falls into.

IOL Chemicals And Pharmaceuticals 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

IOL Chemicals And Pharmaceuticals (NSE:IOLCP) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

IOL Chemicals And Pharmaceuticals 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of IOL Chemicals And Pharmaceuticals's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

IOL Chemicals And Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » IOL Chemicals And Pharmaceuticals Ltd (NSE:IOLCP) » Definitions » 3-Year EBITDA Growth Rate

Traded in Other Exchanges

524164:India

Address

85, Industrial Area, 'A', Ludhiana, PB, IND, 141 003

Website

https://www.iolcp.com

IOL Chemicals And Pharmaceuticals Ltd is an India-based pharmaceutical company. The primary activity of the group is the manufacturing and sale of drugs and organic chemicals. The business activity is functioned through the Chemicals and Pharmaceutical segments. The Chemicals segment produces and sells chemicals such as Ethyl Acetate, Acetic Anhydride, Acetyl Chloride, Mono Chloro Acetic Acid, and Iso Butyl benzene, whereas the Pharmaceutical segment produces and sells various active pharmaceutical ingredients such as Ibuprofen, Metformin, Fenofibrate, Lamotrigine, and others. It derives prime revenue from the Pharmaceutical segment. Geographically, the group's products are sold in both the Indian and international markets.

IOL Chemicals And Pharmaceuticals Headlines

No Headlines